The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for thiotepa (Link Medical Products Pty Ltd)
Active ingredients
thiotepa
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection/Solution for infusion
Indication
Thiotepa is indicated in combination with other chemotherapy medicinal products as conditioning treatment prior to Haematopoietic Progenitor Cell Transplantation (HPCT)
Therapeutic area
Oncocoloy